MedPath

Effect of Unani formulation in low sperm count

Phase 3
Conditions
Health Condition 1: N461- Oligospermia
Registration Number
CTRI/2020/03/023723
Lead Sponsor
uqman Unani Medical College Hospital Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Male patients with oligospermia.

2.Patient having sperm count <15 million/ml and sperm motility of 20%.

3.Patient have ages above 21 years.

4.Informed volunteers giving written consent.

5.Patients who were willing for a follow-up and for semen examination.

6.No history of renal, hepatic disease or any other chronic illness.

Exclusion Criteria

1)Patients of Azoospermia. 2)Patients with any genital infection and congenital genital anomaly.3)Patients suffering from Hypogonadism, Diabetes, any Neurological disorder, mentally retarded personâ??s varicocele. 4)Taking treatment for major psychiatric illness 5)History of previous medications and trauma leading to Oligozoospermia 6)Patient who do not report for follow up.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in sperm countTimepoint: At baseline and After 60 days from baseline <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Change in Motility, Morphology, Semen volumeTimepoint: At baseline and After 60 days from baseline <br/ ><br> <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath